“Bioconvergence is not just a scientific evolution – it’s our strategic bet on the future”

Full list of Israeli high-tech funding rounds in 2025

Zero Networks raises $55M Series C to simplify microsegmentation at scale

Deel hits $1 billion revenue run rate, sets sights on acquisitions and possible IPO